Literature DB >> 10342800

Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study.

C N Bernstein1, J F Blanchard, P Rawsthorne, A Wajda.   

Abstract

The aim of this study was to assess the accuracy and utility of administrative health data in identifying persons with inflammatory bowel disease on a population basis and to determine the incidence and prevalence of this disease in the Canadian province of Manitoba. The data from Manitoba Health (the province's single insurer) were used to identify residents with physician and/or hospital contacts for Crohn's disease or ulcerative colitis based on International Classification of Diseases, Ninth Revision, Clinical Modification, codes between 1984 and 1995. Of 5,182 eligible individuals, 4,514 were mailed questionnaires and 2,725 responded. Cases were defined as individuals with five or more separate medical contacts with one of these diagnoses or three or more such contacts if they were resident for less than 2 years. The accuracy of the study case definitions was high when compared with either self-report or chart review. The 1989-1994 age- and sex-adjusted annual incidence was 14.6/100,000 for Crohn's disease and 14.3/100,000 for ulcerative colitis. The prevalence of Crohn's disease in 1994 was 198.5/100,000, and that of ulcerative colitis was 169.7/100,000. In conclusion, the authors have successfully established and validated a population-based database of inflammatory bowel disease based on administrative data. The high incidence rates and dynamic epidemiology of inflammatory bowel disease in Manitoba indicate the presence of important environmental risk factors, which warrants further investigation.

Entities:  

Mesh:

Year:  1999        PMID: 10342800     DOI: 10.1093/oxfordjournals.aje.a009735

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  151 in total

Review 1.  Cancer surveillance in inflammatory bowel disease.

Authors:  C N Bernstein
Journal:  Curr Gastroenterol Rep       Date:  1999-12

2.  Validation of a case definition for osteoporosis disease surveillance.

Authors:  W D Leslie; L M Lix; M S Yogendran
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

3.  Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease.

Authors:  M Severs; S J H van Erp; M E van der Valk; M J J Mangen; H H Fidder; M van der Have; A A van Bodegraven; D J de Jong; C J van der Woude; M J L Romberg-Camps; C H M Clemens; J M Jansen; P C van de Meeberg; N Mahmmod; C Y Ponsioen; C Bolwerk; J R Vermeijden; M J Pierik; P D Siersema; M Leenders; A E van der Meulen-de Jong; G Dijkstra; B Oldenburg
Journal:  J Crohns Colitis       Date:  2015-12-30       Impact factor: 9.071

4.  A multi-site cognitive task analysis for biomedical query mediation.

Authors:  Gregory W Hruby; Luke V Rasmussen; David Hanauer; Vimla L Patel; James J Cimino; Chunhua Weng
Journal:  Int J Med Inform       Date:  2016-06-16       Impact factor: 4.046

Review 5.  Genotypes and phenotypes in Crohn's disease: do they help in clinical management?

Authors:  C Gasche; P Grundtner
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

6.  Costs of inflammatory bowel disease in Germany.

Authors:  Renee Stark; Hans-Helmut König; Reiner Leidl
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

7.  Accuracy of diagnostic codes for identifying patients with ulcerative colitis and Crohn's disease in the Veterans Affairs Health Care System.

Authors:  Jason K Hou; Mimi Tan; Ryan W Stidham; John Colozzi; Devon Adams; Hashem El-Serag; Akbar K Waljee
Journal:  Dig Dis Sci       Date:  2014-05-10       Impact factor: 3.199

Review 8.  Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children.

Authors:  Theresa A Mikhailov; Sylvia E Furner
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

9.  Suboptimal rates of cervical testing among women with inflammatory bowel disease.

Authors:  Millie D Long; Carol Q Porter; Robert S Sandler; Michael D Kappelman
Journal:  Clin Gastroenterol Hepatol       Date:  2008-10-15       Impact factor: 11.382

10.  Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.

Authors:  Michael D Kappelman; Sheryl L Rifas-Shiman; Carol Q Porter; Daniel A Ollendorf; Robert S Sandler; Joseph A Galanko; Jonathan A Finkelstein
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.